About the Vistara Test

Single Gene NIPT

Vistara looks for small DNA changes, or single-gene mutations, that could affect a baby’s health. Like other non-invasive prenatal tests (NIPTs), Vistara analyses DNA from the placenta that is found in a mother’s blood.

The test:

  • screens for serious genetic conditions (caused by single-gene mutations across 30 genes) that affect quality of life and may benefit from medical and/or surgical intervention
  • screens for a set of disorders that, combined, occur more frequently than Down Syndrome
  • screens for conditions not covered by traditional NIPTs or carrier screening
  • is a simple blood test and can be performed as early as nine weeks into your pregnancy
  • poses no miscarriage risk to your baby.

Screened conditions for Vistara include:

  • Noonan Syndrome
  • Achondroplasia
  • Osteogenesis Imperfecta
  • Rett Syndrome
  • 21 other single-gene disorders across 30 genes

Consider Vistara for the following indications:

  • paternal age (over 40 years)
  • if you’d like to know as much as possible or as an extra to your Panorama Test, CVS or amniocentesis
  • if ultrasound anomalies are identified on your scan (such as shortened long bones, increased NT measurements or cardiac defects)